Patents by Inventor Robert L. Reddick

Robert L. Reddick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutically acceptable fixed-dried human blood platelets
    Patent number: 5993804
    Abstract: Fixed-dried human blood platelets and processes for preparing the same are disclosed. The platelets, upon reconstitution: adhere to thrombogenic surfaces; do not adhere to non-thrombogenic surfaces; undergo shape change (spreading) upon adhering to a thrombogenic surface; adhere to one another to form a hemostatic plug upon adhering to a thrombogenic surface; and release their granular contents. Pharmaceutical formulations containing the same are also disclosed. The platelets are preferably fixed by means of a fixative such as formaldehyde, paraformaldehyde, or glutaraldehyde, or fixed by means of a permanganate fixate. The platelets are preferably dried by lyophilization.
    Type: Grant
    Filed: December 31, 1996
    Date of Patent: November 30, 1999
    Assignees: The University of North Carolina at Chapel Hill, East Caroline University
    Inventors: Marjorie S. Read, Robert L. Reddick, Arthur P. Bode
  • Surgical aids containing pharmaceutically acceptable fixed-dried human blood platelets
    Patent number: 5902608
    Abstract: Fixed-dried human blood platelets and processes for preparing them are disclosed. The platelets, upon reconstitution: adhere to thrombogenic surfaces; do not adhere to non-thrombogenic surfaces; undergo shape change (spreading) upon adhering to a thrombogenic surface; adhere to one another to form a hemostatic plug upon adhering to a thrombogenic surface; and release their granular contents. Surgical aids containing such platelets are also disclosed. The platelets are preferably fixed by a fixative such as formaldehyde, paraformaldehyde, or glutaraldehyde, or fixed by a permanganate fixate. The platelets are preferably dried by lyophilization.
    Type: Grant
    Filed: December 31, 1996
    Date of Patent: May 11, 1999
    Assignees: University of North Carolina at Chapel Hill, East Carolina University
    Inventors: Marjorie S. Read, Robert L. Reddick, Arthur P. Bode
  • Pharmaceutically acceptable fixed-dried human blood platelets
    Patent number: 5651966
    Abstract: Fixed-dried human blood platelets and processes for preparing the same are disclosed. The platelets, upon reconstitution: adhere to thrombogenic surfaces; do not adhere to non-thrombogenic surfaces; undergo shape change (spreading) upon adhering to a thrombogenic surface; adhere to one another to form a hemostatic plug upon adhering to a thrombogenic surface; and release their granular contents. Pharmaceutical formulations containing the same are also disclosed. The platelets are preferably fixed by means of a fixative such as formaldehyde, paraformaldehyde, or glutaraldehyde, or fixed by means of a permanganate fixate. The platelets are preferably dried by lyophilization.
    Type: Grant
    Filed: November 28, 1994
    Date of Patent: July 29, 1997
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Marjorie S. Read, Robert L. Reddick, Arthur P. Bode